An industry-academic consortium received a U.S. government contract to develop coded synthetic polymer chemicals like DNA for reliably storing massive amounts of data. . . . → Read More: Synthetic DNA Studied for Mass Data Storage
|
|||||
|
|
Venture capital deal-making in the U.S. declined in the fourth quarter of 2019, but biotechnology start-ups remained the most sought-after investment targets of any sector. . . . → Read More: Venture Deals, Dollars Fall in Q4 2019; Biotech Stays Hot 
UPMC, the medical center affiliated with University of Pittsburgh, plans to invest $1 billion in life science advances, with spin-off companies as part of its strategy. . . . → Read More: UPMC to Invest $1 Billion in Medical Enterprises 
A team of biologists and computer scientists created tiny robotic devices designed by computer models and made from frog embryo cells. . . . → Read More: Algorithm-Designed Robots Made from Living Cells 
A gene therapy start-up is receiving an award resembling venture financing to advance its treatment for a rare inherited neuromuscular disorder to clinical trials. . . . → Read More: Venture Philanthropy Funds Rare Neuro Disease Trial 
A biotechnology company launched yesterday that plans to discover and develop therapies faster and at lower cost than many of today’s new drugs. . . . → Read More: New Biotech Aims to Bring Down Drug Prices 
The list of 36 companies covers 12 technology categories, including many of the advances we feature at Science & Enterprise . . . → Read More: Infographic – High Momentum Start-Ups to Watch 
Drug maker Boehringer Ingelheim is acquiring an antibody technology that blocks actions of a signaling protein associated with a range of fibrosis diseases. . . . → Read More: Pharma Gains Fibrosis Technology in $1B+ Deal 
A company designing vaccines delivered with a microneedle patch to prevent infectious diseases is raising $11 million in its first venture funding round. . . . → Read More: Vaccine Developer Gains $11M in Early Funds 
A clinical trial is recruiting participants to test an antibiotic made with engineered viruses, in people threatened with urinary tract infections from E. coli bacteria. . . . → Read More: Trial Underway Testing Crispr-Based Antibiotic |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
